Dolphine Medical & Research - 33172 Miami, FL

Business Name: Dolphine Medical & Research
Categorized In: Operators of Nonresidential Buildings
Address: 11251 Nw 20th St Unit 103, Miami, FL 33172
Phone Number: (305) 520-5454
Website Address: taubman.com
NAICS Code: 6214930
SIC Code: 6512
Business Type: B2B (Business to Business)
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $1.000.000 to $2.499.999
Share This Business:
Similar Businesses: Lua Properties Inc - Miami, FL 33172
Lucas Quality Properties Inc - Miami, FL 33172
Vira Property LLC - Miami, FL 33172
Adaproperties 2 - Miami, FL 33172
Wincor Properties LLC - Miami, FL 33172
Ada Properties 2 - Miami, FL 33172
Ada Properties 4 - Miami, FL 33172
Ewe Office Investments Ltd - Miami, FL 33172
Potters Properties - Miami, FL 33172
Mar & Tierra Properties Inc - Miami, FL 33172
Germico Inc - Miami, FL 33172
S E S Properties Inc - Miami, FL 33172
Lnr Property Corp - Miami, FL 33172
Rochester Properties LLC - Miami, FL 33172
Select Properties Of America - Miami, FL 33172
Simon Property Group L P - Miami, FL 33172
N G F Properties LLC - Miami, FL 33172
Z P G Invesment Properties - Miami, FL 33172
Jeade Properties LLC - Miami, FL 33172
Miami Properties Network Corporation - Miami, FL 33172

Dolphine Medical & Research provides professional Operators of Nonresidential Buildings from its single location at the coordinates 25.792491,-80.34243.

The company offers B2B variables under the SIC code 6512 and NAICS code 6214930, while making an annual revenue of $1.000.000 to $2.499.999 and hiring a total of 1 to 4 employees.

Founded in 0, the company can now be visited at 11251 Nw 20th St Unit 103, Miami, Florida 33172 or contacted through representative at (305) 520-5454.

For frequently asked questions and further inquiries about professional Operators of Nonresidential Buildings, get to know more about Dolphine Medical & Research through its company website at taubman.com. Engage with this business on its social media platforms through on Twitter and on Facebook.